This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Brian Hartline: Innovator in Pulmonary Arterial Hypertension Treatment
Introduction
Brian Hartline is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension. His innovative approach has led to the development of a unique method that enhances patient care.
Latest Patents
Brian Hartline holds a patent titled "Transitioning patients treated for pulmonary arterial hypertension to selexipag." This patent outlines methods for transitioning patients who are being treated with a non-selexipag prostacyclin pathway agent to selexipag, which is crucial for improving treatment outcomes.
Career Highlights
Brian is currently associated with Actelion Pharmaceuticals Ltd., a company known for its focus on innovative treatments for pulmonary diseases. His work at Actelion has allowed him to contribute to advancements in patient care and treatment methodologies.
Collaborations
Throughout his career, Brian has collaborated with talented professionals, including Carol Zhao and Wade Benton. These collaborations have fostered an environment of innovation and have led to the development of effective treatment strategies.
Conclusion
Brian Hartline's contributions to the field of pulmonary arterial hypertension treatment exemplify the impact of innovation in medicine. His patent and work at Actelion Pharmaceuticals Ltd. highlight his commitment to improving patient outcomes.